Oxford Cannabinoid Technologies Holdings (LSE:OCTP) ROE % Adjusted to Book Value : -37.60% (As of Oct. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Oxford Cannabinoid Technologies Holdings ROE % Adjusted to Book Value?

Oxford Cannabinoid Technologies Holdings's ROE % for the quarter that ended in Oct. 2023 was -136.47%. Oxford Cannabinoid Technologies Holdings's PB Ratio for the quarter that ended in Oct. 2023 was 3.63. Oxford Cannabinoid Technologies Holdings's ROE % Adjusted to Book Value for the quarter that ended in Oct. 2023 was -37.60%.

Oxford Cannabinoid Technologies Holdings ROE % Adjusted to Book Value Historical Data

The historical data trend for Oxford Cannabinoid Technologies Holdings's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxford Cannabinoid Technologies Holdings ROE % Adjusted to Book Value Chart

Oxford Cannabinoid Technologies Holdings Annual Data

Trend

May18

May19

May20

May21

Apr23

ROE % Adjusted to Book Value

-16.34

-18.32

Oxford Cannabinoid Technologies Holdings Semi-Annual Data
	May19	Nov19	May20	Nov20	May21	Nov21	Oct22	Apr23	Oct23
ROE % Adjusted to Book Value	Get a 7-Day Free Trial				-12.88	-16.69	-83.31	-24.87	-37.60

Competitive Comparison of Oxford Cannabinoid Technologies Holdings's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Oxford Cannabinoid Technologies Holdings's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oxford Cannabinoid Technologies Holdings's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oxford Cannabinoid Technologies Holdings's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Oxford Cannabinoid Technologies Holdings's ROE % Adjusted to Book Value falls into.

Oxford Cannabinoid Technologies Holdings ROE % Adjusted to Book Value Calculation

Oxford Cannabinoid Technologies Holdings's ROE % Adjusted to Book Value for the fiscal year that ended in Apr. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-65.60%	/	3.58
	=	-18.32%

Oxford Cannabinoid Technologies Holdings's ROE % Adjusted to Book Value for the quarter that ended in Oct. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-136.47%	/	3.63
	=	-37.60%

Oxford Cannabinoid Technologies Holdings ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Oxford Cannabinoid Technologies Holdings's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Oxford Cannabinoid Technologies Holdings (LSE:OCTP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford Cannabinoid Technologies Holdings PLC (LSE:OCTP) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

0CB:Germany

Address

267 Banbury Road, Prama House, Oxford, GBR, OX2 7HT

Website

https://www.oxcantech.com

Oxford Cannabinoid Technologies Holdings PLC is a pharmaceutical company engaged in cannabinoid drug development. The company uses a drug development that includes proprietary cannabinoid derivatives, natural phytocannabinoids (pCBs), and in-licensed compounds. Its primary market focus is the pain market, and OCT initially aims to develop a portfolio of four drug candidates for approval as licensed pain medicines.

Oxford Cannabinoid Technologies Holdings (LSE:OCTP) Headlines

No Headlines